IL6 and metabolic syndrome: The diverse pathogenic mechanisms driving the progression of metabolic syndrome converge to create a pro-inflammatory state, which accounts for the elevated levels of inflammatory markers like Interleukin 6 (IL-6), C-reactive protein (CRP), and Tumor Necrosis Factor Alpha (TNFα) observed in individuals with MetS [17].